HomeTMO • NYSE
Thermo Fisher Scientific Inc
add
$488.12
0.074%
After Hours:(0.00%)0.00
$488.12
Closed: Aug 27, 4:20:00 PM UTC-4 · USD · NYSE · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 10.86B | 2.98% |
Operating expense | 2.48B | -1.47% |
Net income | 1.62B | 4.46% |
Net profit margin | 14.90 | 1.43% |
Earnings per share | 5.36 | -0.19% |
EBITDA | 2.62B | -0.04% |
Effective tax rate | 5.38% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.39B | -27.58% |
Total assets | 101.23B | 2.78% |
Total liabilities | 50.63B | -0.66% |
Total equity | 50.60B | — |
Shares outstanding | 377.61M | — |
Price to book | 3.65 | — |
Return on assets | 4.84% | — |
Return on capital | 5.71% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 1.62B | 4.46% |
Cash from operations | 1.40B | -28.62% |
Cash from investing | -288.00M | -13.83% |
Cash from financing | -991.00M | -761.74% |
Net change in cash | 431.00M | -72.69% |
Free cash flow | 736.13M | -44.08% |
Previous close
$488.48
Day range
$482.98 - $490.98
Year range
$385.46 - $627.88
Market cap
184.32B USD
Avg Volume
2.73M
P/E ratio
28.25
Dividend yield
0.35%
Primary exchange
NYSE
About
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation, Alfa Aesar, Affymetrix, FEI Company, BD Advanced Bioprocessing, and PPD.
It ranked 104th on the Fortune 500 list based on its 2024 annual revenue of $42.879 billion.
Thermo Fisher announced a $2 billion investment over four years in the U.S., including $1.5 billion for expanding manufacturing capacity and $500 million for R&D investment. This initiative aims to bolster domestic biotech manufacturing, create high-paying jobs, and reinforce the U.S. healthcare supply chain. Wikipedia
Founded
1956
Headquarters
Website
Employees
125,000
